Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELDERCARE-AF: Edoxaban in Elderly NVAF Patients Ineligible for Standard Anticoagulation
NCT02801669Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2016; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02801669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801669.